Leading the field through patient-centric testing

Mayo Clinic has been recognized as the No. 1 gastroenterology and gastrointestinal surgery hospital in the nation by U.S. News & World Report every year since 1990. Backed by the experience and knowledge of more than 140 digestive disease specialists, our disease-specific tests are clinically reinforced, cost-effective, and developed with patients in mind. The clinically actionable information enabled by these assays is a contributing factor in establishing Mayo Clinic's premier status in this area.

A collaboration with Mayo Clinic BioPharma Diagnostics includes access to Mayo Clinic Laboratories' robust gastroenterology test catalog, which features more than 330 tests to confirm diagnosis, monitor disease, and guide therapies. Whether performing routine serological testing or advanced biomarker evaluations, our tests enable insights to advance our partners' clinical trials goals.

Full-spectrum gastroenterology disease testing

A collaboration with Mayo Clinic BioPharma Diagnostics includes access to the gastroenterology disease testing capabilities of Mayo Clinic Laboratories, including:

  • Inflammatory bowel disease
  • Therapeutic drug monitoring
  • Intestinal infections
  • Chronic liver disease
  • Celiac disease
  • Pancreatic disease
  • Autoimmune testing
  • Metabolite monitoring
  • Noninvasive mucosal healing tests
  • Antibody testing

For a complete list of Mayo Clinic Laboratories' clinically available gastroenterology tests, visit our test catalog. Mayo Clinic BioPharma Diagnostics partners can access gastroenterology testing for clinical trials and be among the first to use up-and-coming tests currently in development.

Learn more about how we can work together.